雜志介紹

Cancer Treatment Reviews雜志介紹

《Cancer Treatment Reviews》是一本以English為主的未開放獲取國際優秀期刊，中文名稱癌癥治療評論，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為9.6，最新CiteScore 指數為21.4。

本刊近期中國學者發表的論文主要有：

• Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges

  Author: Yu, Ying; Yang, Yehao; Li, Hui; Fan, Yun

• Targeting protein kinases to reverse multidrug resistance in sarcoma.

  Author: Chen H, Shen J, Choy E, Hornicek FJ, Duan Z.

• Personalized therapy for hepatocellular carcinoma: Where are we now?

  Author: Chan SL, Wong AM, Lee K, Wong N, Chan AK.

• New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients

  Author: Paolo Pronzato

英文介紹

Cancer Treatment Reviews雜志英文介紹

Cancer Treatment Reviews

Welcome to the online submission and editorial system for Cancer Treatment Reviews.

Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.

Each issue provides topical reviews under the following regular sections:

? comments on controversy

? tumor reviews

? anti-tumor treatments

? new drugs

? complications of treatment

? general and supportive care

? laboratory/clinic interface.